(CGCB) Capital Fixed Income Trust - Ratings and Ratios
Bonds, Debt Securities, Derivatives
Dividends
| Dividend Yield | 4.21% |
| Yield on Cost 5y | 4.89% |
| Yield CAGR 5y | 309.96% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 3.49% |
| Value at Risk 5%th | 5.98% |
| Relative Tail Risk | 4.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | 2.08 |
| CAGR/Max DD | 1.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.343 |
| Beta | 0.014 |
| Beta Downside | -0.013 |
| Drawdowns 3y | |
|---|---|
| Max DD | 5.17% |
| Mean DD | 1.40% |
| Median DD | 1.13% |
Description: CGCB Capital Fixed Income Trust November 10, 2025
The Capital Group Fixed Income ETF Trust (CGCB) aims to deliver current income while preserving capital, allocating at least 80% of its assets to bonds and related debt securities, including derivatives such as futures and swaps. The fund’s non-diversified structure concentrates exposure in a relatively narrow set of credit markets.
Key performance indicators (as of the most recent quarterly report) include an annualized distribution yield of roughly 4.2%, an average portfolio duration of about 5.5 years, and an expense ratio of 0.20%. The fund manages approximately $2.3 billion in assets, with a credit quality tilt toward investment-grade issuers (≈ 85% AA-BBB).
Primary economic drivers for CGCB’s performance are Federal Reserve policy (interest-rate outlook), inflation trends, and corporate credit-spread dynamics. A tightening cycle typically depresses bond prices, while a flattening yield curve can benefit intermediate-term holdings. Additionally, the health of the U.S. corporate bond issuance market influences supply and pricing for the ETF’s core sector exposure.
For a deeper, data-driven assessment of CGCB’s risk-adjusted returns, you might explore ValueRay’s analytical tools to compare its metrics against peer ETFs and benchmark indices.
What is the price of CGCB shares?
Over the past week, the price has changed by +0.11%, over one month by +0.36%, over three months by +0.54% and over the past year by +6.31%.
Is CGCB a buy, sell or hold?
What are the forecasts/targets for the CGCB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32.1 | 20.7% |
CGCB Fundamental Data Overview December 12, 2025
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.51b USD (3.51b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.51b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.51b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.07% (E(3.51b)/V(3.51b) * Re(6.07%) + (debt-free company))
Discount Rate = 6.07% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for CGCB ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle